A number of pharmaceutical companies who use Orchestrate as their day-to-day production scheduling and capacity tool are also exploiting its functionality to address key strategic issues. In this case study, we visit a plant belonging to one of the world’s largest pharmaceutical companies, where Orchestrate has been employed in two major initiatives. The first, to boost productivity, significantly increasing capacity for the years ahead while using existing facilities. The second initiative is using Orchestrate’s modelling capabilities in a multi-million project to rationalise production, moving plant from one continent to another to create a ‘greenfield’ suite.